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background:  The 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (PCI) considered drug-eluting stents (DES) as a 
useful alternative to bare-metal ones (BMS). The hypotheses of this study are that the use of DES is non-random in unstable angina (UA) or non ST-
elevation myocardial infarction (NSTEMI) patients undergoing PCI and that DES use is associated with better outcomes.
methods: Prospectively-collected data of UA/NSTEMI patients undergoing PCI from 01/01/2011 till 03/31/2013 at 2 tertiary care centers in New 
York was analyzed. The results were confirmed with propensity-score-adjusted analysis. The primary endpoint was death (index admission or 30-day), 
the secondary adverse outcome (composite of death, dissection, perforation, myocardial infarction, cerebrovascular accident, bleeding, transfusion, 
and coronary artery bypass graft).
results: Of the 4,687 study subjects, those with DES (n = 4,269 (91%)) were on average younger, Asian, non-Hispanics, with private insurance, 
lesser prevalence of comorbidities, smaller vessel diameter, and had longer stents than patients with BMS. In propensity-score adjusted logistic 
regression analysis, DES use was associated with lower mortality and adverse outcomes (Table).
Conclusion: In UA/NSTEMI patients undergoing PCI, DES were more often deployed in younger, Asian, non-Hispanic patients, with private insurance 
and lesser comorbidities. DES use was associated with lower mortality and adverse outcomes.
